Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study-Reference-Cited by-同舟云学术

Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study

Published:2018-09-21 Issue:1 Volume:18 Page:
ISSN:1471-2458
Container-title:BMC Public Health
language:en
Short-container-title:BMC Public Health

Author:

Gómez-Acebo Inés,Dierssen-Sotos Trinidad,de Pedro María,Pérez-Gómez Beatriz,Castaño-Vinyals Gemma,Fernández-Villa Tania,Palazuelos-Calderón Camilo,Amiano Pilar,Etxeberria Jaione,Benavente Yolanda,Fernández-Tardón Guillermo,Salcedo-Bellido Inmaculada,Capelo Rocío,Peiró Rosana,Marcos-Gragera Rafael,Huerta José M.,Tardón Adonina,Barricarte Aurelio,Altzibar Jone-Miren,Alonso-Molero Jessica,Dávila-Batista Verónica,Aragonés Nuria,Pollán Marina,Kogevinas Manolis,Llorca Javier

Funder

the Instituto de Salud Carlos III-FEDER

Fundación Marqués de Valdecilla

ICGC International Cancer Genome Consortium CLL

Junta de Castilla y León

Consejería de Salud of the Junta de Andalucía

Conselleria de Sanitat of the Generalitat Valenciana

Recercaixa

Regional Government of the Basque Country

European Commission

Spanish Association Against Cancer (AECC) Scientific Foundation and by the Catalan Government DURSI

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1186/s12889-018-6019-z.pdf

Reference27 articles.

1. Scarpignato C, Hunt RH. Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention. Gastroenterol Clin N Am. 2010;39:433–64.

2. Fanelli A, Ghisi D, Aprile PL, Lapi F. Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications. Ther Adv Drug Saf. 2017;8:173–82.

3. Chan FKL, Abraham NS, Scheiman JM, Laine L. First international working party on gastrointestinal and cardiovascular effects of nonsteroidal anti-inflammatory drugs and anti-platelet agents. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents. Am J Gastroenterol. 2008;103:2908–18.

4. Scarpignato C, Lanas A, Blandizzi C, Lems WF, Hermann M, Hunt RH, et al. Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. BMC Med. 2015;13:55.

5. FDA. Drug Safety and Availability - FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. 2015. https://www.fda.gov/Drugs/DrugSafety/ucm451800.htm . Accessed 8 Sept 2017.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Environmental and Nutritional Factors in the Development of Inflammatory Bowel Diseases: A Case–Control Study;Nutrients;2024-07-29

2. Global burden and risk factors of gastritis and duodenitis: an observational trend study from 1990 to 2019;Scientific Reports;2024-02-01

3. Hypoxia, NSAIDs, and autism: A biocultural analysis of stressors in gametogenesis;American Journal of Human Biology;2024-01-29

4. ВИВЧЕННЯ ПРОТИЗАПАЛЬНИХ ВЛАСТИВОСТЕЙ ЕКСТРАКТІВ З КОРЕНІВ GENTIANA ASCLEPIADEA L.;Medical and Clinical Chemistry;2024-01-09

5. Why Pharmacovigilance of Non-steroidal Anti-inflammatory Drugs is Important in India?;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-10-04